Literature DB >> 9263285

The Bridgeport Hospital experience with autologous transfusion in orthopedic surgery.

L H Bernstein1, M Coles, A Granata.   

Abstract

The transfusion records of 341 orthopedic patients who donated blood preoperatively in the years 1992 and 1993 were audited to review the transfusion practices associated with the surgical procedures. The study sample underwent 182 total knee (TKA), 123 total hip (THA) arthroplasties, and 33 laminectomies with fusion (LAM) and 3 without. Data used were age, gender, predonation hemoglobin concentration (Hbd), initial (Hbi) and final (Hbf) hemoglobin concentration, surgical procedure, surgical blood order (SBO), and estimated blood loss (EBL). We analyzed for means and associations and differences between covariates. The means of EBL (mL), transfused units, donated units, Hbi, (g/dL), Hbd, and Hbf (g/dL) for the most common procedures were: TKA--272, 1.1, 2.1, 10.4, 13.9, and 10.1; THA--951, 2.3, 2.4, 9.4, 13.8, and 9.9; and LAM--589, 1.5, 2.2, 12.0, 14.6, and 11.2. Phlebotomies for procedures with minimal blood loss, as for total knee arthroplasties, result in wastage. Autodonation under such circumstances takes patients to an unnecessary low hemoglobin concentration prior to either retransfusing the blood taken or discarding part of it. The number of preoperative autologous units donated can be reduced if predonation hemoglobin concentration is > 15 g/dL and expected blood loss is not > 2 g.

Entities:  

Mesh:

Year:  1997        PMID: 9263285     DOI: 10.3928/0147-7447-19970801-05

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  2 in total

1.  Blood loss in total knee arthroplasty: an analysis of risk factors.

Authors:  Narayana Prasad; Vinod Padmanabhan; Arun Mullaji
Journal:  Int Orthop       Date:  2006-03-28       Impact factor: 3.075

2.  A comparison of autologous and homologous transfusions in spinal fusion.

Authors:  Moon-Soo Park; Seong-Hwan Moon; Hak-Sun Kim; Soo-Bong Hahn; Hui-Wan Park; Si-Young Park; Hwan-Mo Lee
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.